Every interaction Magellan has curated between the supplements it covers and prescription or over-the-counter medication, published in full: 104 distinct entries (116 records before duplicate formulations of the same ingredient are merged) across 34 supplements and 36 medication classes. 12 are graded major, 57 moderate and 35 minor. Each one names the mechanism, the direction the risk runs, and the clinical reference it came from.
This is deliberately not a sales page. Several of the supplements with the most serious documented interactions are products Magellan links to and earns commission on — they are reported here exactly as the sources state them, in the same detail as everything else. Safety content that softens a risk to protect a sale is worthless to the reader and, eventually, to the site.
Magellan’s Medication Safety Check runs entirely on your device — type the medicines you take and it flags every documented interaction in this dataset. Nothing you type is sent anywhere.
Open the Medication Safety Check →Every entry on this hub has the same five parts, and reading them in order tells you almost everything you need before you pick up the phone.
Severity describes the interaction as the cited reference frames it, not how a specific person will react. A “minor” entry in someone with kidney disease, on five other drugs, can matter more than a “major” one in someone on nothing else.
Start here if you know what you take.
22 documented interactions across 17 supplements · 7 major.
15 documented interactions across 14 supplements.
9 documented interactions across 9 supplements · 1 major.
9 documented interactions across 9 supplements.
9 documented interactions across 9 supplements · 1 major.
7 documented interactions across 6 supplements.
7 documented interactions across 7 supplements · 1 major.
5 documented interactions across 4 supplements · 1 major.
43 documented interactions across 24 supplements · 1 major.
Every supplement in this dataset with at least one documented interaction. Supplements with two or more have their own page; the rest are set out in full further down this page rather than given a page too thin to be worth reading.
These 6 supplements each have exactly one interaction on record. One entry cannot carry a page worth reading, so they are published here in full rather than spun into thin pages — same detail, same citation, same routing.
Mayo Clinic notes taking caffeine together with creatine might reduce how well creatine works, though more research is needed; a study in Parkinson's disease patients also flagged faster disease progression in those combining high-dose caffeine with creatine, but this needs further investigation.
Taurine may interfere with cytochrome P450 enzymes used to metabolize these drug classes at supplemental (not typical energy-drink) doses, though this is a general mechanism-based caution rather than itemized per-drug clinical data.
Medicines in this group include: Atorvastatin (Lipitor), Simvastatin (Zocor), Rosuvastatin (Crestor), Lovastatin (Mevacor, Altoprev), Pravastatin (Pravachol), Pitavastatin (Livalo), Fluvastatin (Lescol), Sertraline (Zoloft) and 25 more.
Carnosine may itself lower blood pressure; combining it with blood pressure-lowering medication could cause blood pressure to drop excessively.
Medicines in this group include: Amlodipine (Norvasc), Diltiazem (Cardizem, Tiazac), Verapamil (Calan, Verelan), Nifedipine (Procardia, Adalat), Hydrochlorothiazide (Hctz, Microzide), Chlorthalidone (Thalitone), Indapamide (Lozol), Furosemide (Lasix) and 6 more.
Boswellic acid compounds can inhibit platelet aggregation, which may add to the bleeding risk of blood-thinning medications.
Medicines in this group include: Warfarin (Coumadin, Jantoven), Apixaban (Eliquis), Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Edoxaban (Savaysa), Heparin (Lovenox, Enoxaparin), Acenocoumarol (Sintrom), Aspirin (Asa, Bayer aspirin) and 4 more.
Pine bark extract may inhibit platelet aggregation, which could add to the bleeding risk of blood-thinning medications.
Medicines in this group include: Warfarin (Coumadin, Jantoven), Apixaban (Eliquis), Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Edoxaban (Savaysa), Heparin (Lovenox, Enoxaparin), Acenocoumarol (Sintrom), Aspirin (Asa, Bayer aspirin) and 4 more.
NCCIH does not name a specific well-established drug pairing on its consumer safety page, but explicitly cautions that milk thistle can interact with medicines in harmful ways and advises anyone on any medication to talk with their health care provider before use; it also flags that some milk thistle products are inconsistent in silymarin content or contaminated with pesticides/mycotoxins.
These are the warning signs that go with the medication classes on this page. They are general safety-netting, not a prediction that any supplement will cause them.
If something feels seriously wrong, do not wait for an appointment. Call 911 (US) or your local emergency number.
Curated from NIH ODS, NCCIH, MedlinePlus, Mayo Clinic, Memorial Sloan Kettering 'About Herbs', and similar clinical references. Not a substitute for medical advice.
Entries by source domain: mskcc.org (24), ods.od.nih.gov (22), mayoclinic.org (12), nccih.nih.gov (11), rxlist.com (9), webmd.com (8), health.clevelandclinic.org (5), goodrx.com (5), drugs.com (2), sciencedirect.com (1), mdpi.com (1), nature.com (1), dhpp.hpfb-dgpsa.ca (1), pubmed.ncbi.nlm.nih.gov (1), hellopharmacist.com (1). Every entry links out to the specific page it was drawn from, so you can read the original rather than take our word for it.
This is a curated set of interactions with citations — not an exhaustive pharmacology database. An interaction that is absent here has not been ruled out; it may simply not be documented in the references Magellan curates from. Supplements are also not batch-tested for identity or contamination the way prescription drugs are, so what is on the label is a claim rather than a guarantee. And most of these entries come from case reports and mechanistic work rather than randomized trials, which is exactly why the sensible response is a pharmacist review rather than either alarm or dismissal.
The evidence-graded supplement guide · The research map · NMN · Senolytics · Omega-3 · Berberine · Creatine · How Magellan grades evidence
Find your supplement in the A–Z below and read the entries, or find your drug class. For a check against your whole list at once, use Magellan's Medication Safety Check — it runs on your device, accepts brand or generic names, and flags every documented interaction in this dataset. Then take the result to your pharmacist; a full-list review is free at almost every pharmacy and it catches things no database can.
It means no interaction is documented for it in the clinical references Magellan curates from — not that it has been tested and cleared. Of the supplements in this dataset, 34 have at least one documented interaction and the rest have none on record. Absence of evidence is not evidence of safety, which is why we do not publish a page saying any supplement is safe.
Major means the cited reference describes a clinically significant risk — clear it with a clinician before starting. Moderate means a real documented interaction that usually calls for monitoring, dose separation, or a prescriber-led dose change. Minor means documented but usually low-impact, or based on mechanism and animal data rather than human events. There are 12 major, 57 moderate and 35 minor entries in this dataset.
Curated from NIH ODS, NCCIH, MedlinePlus, Mayo Clinic, Memorial Sloan Kettering 'About Herbs', and similar clinical references. Not a substitute for medical advice. The most-cited sources here are mskcc.org (24 entries), ods.od.nih.gov (22 entries), mayoclinic.org (12 entries), nccih.nih.gov (11 entries). Every entry on every page links out to the reference it came from.
No. Magellan earns commission on some of the products named on these pages, and several of the supplements with major documented interactions are products we link to. The interaction, its severity and its citation are reported exactly as the source states them. A supplement's evidence grade and its safety entries are produced independently of any commercial relationship.